ABSTRACT
INTRODUCTION
Colorectal cancer is a significant cause of mortality in both men and women and its etiology is multifactorial and complex (Jemal et al. 2011 ). According to the World Health Organization, colorectal cancer is the fourth most common type of cancer, with an estimated 940,000 new cases annually (World Health Organization 2013) . Colorectal cancer refers to the cancerous growth in the colon, rectum, or cecum (Bose et al. 2014) . The first indication of the development of colorectal cancer is the presence of aberrant crypt foci (ACF), preneoplastic lesions in the colonic mucosa that exhibit morphological changes such as dysplasia and abnormal proliferation. The number of such foci is a useful marker to determine the risk of developing colorectal cancer (Stevens et al. 2007) . As colon cancer is a public health issue, new strategies are needed to reduce its high prevalence. It is estimated that 80% of the world population uses the products derived from the plants in their basic healthcare. Biodiversity is a great reservoir of bioactive secondary metabolites that are used for the production of therapeutic drugs for the treatment of different human pathologies, including cancer (Ranawat et al. 2010) . Bathysa cuspidata (A. St. Hil.) Hook f. belongs to the Rubiaceae family. An infusion of its stem bark is used in popular medicine as an antiinflammatory and healing agent, and for the treatment of various disorders, including stomach and liver problems (Botsaris 2007; Novaes et al. 2012) . Studies have shown positive effects in the prevention and treatment of pulmonary and liver disorders by using ethanolic extracts of the leaves and bark of this species with no mutagenic effects. Use of the B. cuspidata extract to treat pulmonary and liver disorders is believed to be associated with an antioxidant potential effect, mainly in the animals exposed to chemical agents, such as carbon tetrachloride (CCl 4 ) and paraquat Novaes et al. 2012) . Given the demonstrated benefits of the extract of B. cuspidata and the interest in developing new drugs from natural plant products, the purpose of this study was to evaluate the chemo-preventive effect of B. cuspidata extract on the rats with preneoplastic colorectal lesions, induced with the carcinogen 1,2-dimethylhydrazine (DMH).
MATERIAL AND METHODS

Preparation of the plant extract
Samples of B. cuspidata were collected in a biome of Brazilian Atlantic forest in the Minas Gerais state, Brazil and deposited in the herbarium of the Federal University of Viçosa under registration VIC 21559. The bark of B. cuspidata was air-dried at 38°C for two days and then triturated. The powdered bark (500 g) was exhaustively extracted by percolation with 95% ethanol. The extract was concentrated under vacuum at 45°C using a rotary evaporator and then lyophilized until complete removal of the solvent, yielding an ethanolic extract of 135 g.
Phytochemical characterization of the extract
To measure the total phenol and proanthocyanidin contents, the powdered stem bark (1.0 g) was extracted with 200 mL of water at 100°C under reflux for 30 minutes. The concentration of total phenols was determined colorimetrically (absorbance at 760 nm) using the Folin-Ciocalteu method (Verza et al. 2007 ). The proanthocyanidin content was determined according to the method of Price et al. (1980) .The results were expressed in milligram catechin equivalents per gram of dry matter. The content of total flavonoids was determined using rutin as the reference compound. This method was based on the formation of a flavonoid-aluminum trichloride complex, with maximum absorption at 420 nm. The absorption of standard rutin solution in methanol was measured under the same conditions. All the determinations were performed in triplicate and the results were averaged (Boll et al. 2001) . Chromatographic analysis was performed on a Shimadzu LC-20 AD UFLC system (Shimadzu Corp., Tokyo, Japan).
Ethical considerations
The experimental procedures were conducted in accordance with the Ethical Principles in Animal Experimentation, adopted by the Brazilian National Council for the Control of Animal Experimentation (CONCEA), with the approval of the Ethics Committee of the Department of Veterinary Medicine of the Federal University of Viçosa in Brazil (approval protocol 169/2009).
Animals and experimental design
The case-control study lasted for 15 weeks. Forty male rats (Rattusnorvegicus: var. albinus, Rodentia, Mammalia), 72 days old, with an average initial weight of 315 ± 22 g were used for the study. The rats were obtained from the Central Animal House at the Biological Sciences Center at the Federal University of Viçosa. Preneoplastic lesions were induced in all the 40 animals with DMH. The animals were randomly divided into four experimental groups, with treatments administered by gavage: saline (control group, oral administration of saline solution 0.9%); DMSO (vehicle control); B200 (treated with 200 mg/kg of bark extract), and B400 (treated with 400 mg/kg of bark extract). Each experimental group contained ten animals that received standard Nuvilab® food (composition: 19.0% protein, 56.0% carbohydrate, 3.5% fat, 4.5% cellulose, 5.0% vitamins and minerals, totaling 13.87 kJ/g) and filtered water ad libitum.
The ethanolic bark extract was re-suspended in 1.0 mL (w/v) of vehicle DMSO (w/v) before being administered by gavage. The animals received treatment every 48 h for a period of 15 weeks. The animals were maintained in individual cages at 22 ± 1ºC, relative air humidity of 60-70%, and controlled light/dark cycle of 12 h. The body weights were measured each week during the experimental period.
Colorectal carcinogenesis protocol
Preneoplastic colorectal lesions were induced by giving an intraperitoneal injection of 40 mg DMH/kg body weight, two times a week over two weeks for a total of four applications, as previously reported by Larangeira et al. (1998) . The DMH was dissolved in a solution of 0.9% NaCl, 1.5% EDTA (ethylenediaminetetraaceticacid) and 10 mM sodium citrate and the final pH was adjusted to pH 8.0.
Euthanasia, material collection and aberrant crypt foci counting
After 15 weeks of treatment, the animals were anesthetized with Halothane (Tanohalo ®, Cristália, Brazil). The livers were removed and weighed and then stored at -80°C for later analysis. The hepatosomatic index (LSI) was calculated as LSI = (liver weight/body weight) × 100 (Fassini et al. 2011) . The large intestine from the cecum to the anus was removed for the analysis of the ACF. It was washed in saline solution, opened longitudinally along the counter-mesenteric border, and fixed in 10% formaldehyde. After 48 h of fixation, the intestine was divided into three fragments (proximal, middle, and distal regions) of equal length. The fragments were stained with 0.1% methylene blue for approximately two minutes, washed in phosphate buffer, and examined using optical microscopy at ×40 magnification, according to the technique described by Bird (1987) . The number of ACF on the mucosal surface of the colon was counted from the cecum to the rectum by two observers in a double-blind manner. The ACF were categorized as foci with fewer than three crypts, or foci with more than three crypts ).
Determination of biochemical parameters in the serum
The serum was obtained after centrifugation at 3000 x g and stored at -80 C for later analysis. Aspartate amino transferase (AST), alanine amino transferase (ALT), and alkaline phosphatase (ALP) were analyzed in the serum using diagnostic test kits (Bioclin®, Diagnostica®, Belo Horizonte, Brazil) in an auto analyzer equipment (COBAS MIRA Plus, Roche Diagnostic Systems, Branchburg Inc., NJ, USA). Nitric oxide (NO) production was quantified by the standard Griess reaction according to the method of Ricart-Janéet al. (2002) .
Oxidant status markers in the liver
Antioxidant system biomarkers Each liver sample (100 mg/mL buffer) was homogenized in 50 mM phosphate buffer (pH 7.0), with 1% Triton X-100 (pH 7.0). The homogenate was centrifuged at 11 290 x g at 4 C for 10 min, and the supernatant was used for biochemical analysis. The catalase (CAT) activity was evaluated according to the method described by Aebi (1974) by measuring the rate of decomposition of hydrogen peroxide; the results were expressed as units of catalase/milligram of protein. For the analysis of superoxide dismutase (SOD), the hepatic tissue homogenate (100 mg/mL buffer) was homogenized in 50 mM of phosphate buffer (pH 7.0). The SOD activity was determined by an adapted method of Dieterichet al. (2000) . The degree of inhibition of pyrogallol (1,2,3-trihidroxybenzen) auto-oxidation in the supernatant was measured and absorbance was read at 570 nm. The results are expressed as units SOD/mg of protein
Peroxidation biomarkers
The liver concentration of malondialdehyde (MDA) was determined according to the method of Buege and Aust (1978) . An aliquot of frozen liver (100 mg) was homogenized in 50 mM of phosphate buffer (pH 7.0) and then reacted with thiobarbituric acid (TBA). Formation of the thiobarbituric acid-reactive species (TBARS) was monitored at 535 nm. The level of the plasma protein oxidative damage indicated by the protein carbonyl content was measured according to the method of Levine et al. (1990) , where 2,4-dinitrophenylhydrazine reacted with the protein carbonyl group and protein hydrazones were generated, which were detected spectrophotometrically, with maximum absorbance at 370 nm. The results were expressed as peroxidation biomarkers of millimole per milligram (mmol/mg) of protein
Determination of protein concentration
Protein concentration in the tissue homogenates was measured by the method of Lowry et al. (1951) using bovine serum albumin as a reference.
Statistical analysis
Results are presented as the mean values with standard errors. Statistical significance of the differences among the groups was assessed by one-way analysis of variance (ANOVA), followed by Dunn's, or Tukey's post hoc multiple comparison tests, using the GraphPad Prism (GraphPad Software Inc, San Diego, CA, USA). For statistical analysis, p < 0.05 was considered to be statistically significant.
RESULTS
Chemical profile of the extract
The ethanolic extract of B. cuspidata gave rise to four major peaks related to the constituents belonging to the class of polyphenols. The total phenol and proanthocyanidin content comprised of 45.0 mg/g of dry matter (expressed as pirogalol) and 27.9 mg/g of dry matter (expressed as catechin), respectively. The total flavonoid content was 6.0 mg/g dry matter using the calibration curve of rutin.
Effect of treatment with B. cuspidata extract on the physiological parameters in rats
The results of the final bodyweight, liver height, and LSI are presented in Table 1 . The animals in the four treatment groups had similar body weight at the beginning of the experiment (p = 0.396). However, after 15 weeks, the animals treated with the bark extract of B. cuspidata (B200 and B400) had lower body weight (p< 0.001) than the animals in the saline (control) group. Only the B200 group had lower liver weight relative to the saline group (p = 0.006). The B400 group had a higher LSI than all the other groups (p = 0.012). There were no significant differences in AST and ALT among the groups (Table 1 ). The serum levels of ALP were significantly higher in the DMSO and B400 groups, compared to the saline group (p = 0.018). The supplementation of animals with B. cuspidata extract did not affect the plasma levels of nitric oxide (NO) (p > 0.05, data not shown). Oxidative stress markers and antioxidant enzymes Enzymes involved in the endogenous antioxidant defense system were evaluated to measure the antioxidant activity of B. cuspidata extract (Fig.  1) . No differences in CAT were found among the treatments (p = 0.08, Fig.1A ). The DMSO, B200, and B400 groups had lower hepatic activity of SOD compared to the saline group (p = 0.0003, Fig. 1B ). The products of lipid and protein oxidation were also evaluated. The DMSO group had higher levels of MDA compared to the saline group (p = 0.0096, Fig. 1C ). The consumption of B. cuspidata extract did not affect the levels of protein carbonyl (p> 0.05, Fig. 1D ).
Aberrant crypt foci count in the colonic mucosa
The results of the ACF are presented in Table 2 . In the proximal and medial portions of the intestinal mucosa of animals, there were no differences in the incidence of ACF with lower multiplicity ( 3 ACF), or higher multiplicity (> 3 ACF, p> 0.05).
In the distal portion, fewer lower multiplicity ACF were found in the B400 group than in the B200 group (p = 0.040). There was a reduction of ACF in the animals treated with B400 extract compared to the saline, DMSO, and B200, across all portions of the intestinal mucosa of the animals (p = 0.018). 
DISCUSSION
Medicinal plants have a long history of use in the therapy throughout the world. In the 1960s, the National Cancer Institute (USA) began screening plant extracts with antitumor activity. Since then, several natural compounds have been isolated and used as novel anticancer drugs. A plant, or its extracts must be safe and effective to be used in the formulation of therapeutic drugs (Cai et al. 2004; Atanassova et al. 2011) . With that in mind, and considering the increase in the incidence of colorectal cancer worldwide, the effect of the extract of the bark B.cuspidata was investigated on the appearance of ACF in rats, after induction with DMH, as well as its effect on the physiological and biochemical parameters of the animals.
Chemically-induced models of preneoplastic colorectal lesions and carcinogenesis in rodents have been shown to be adequate for the study of risk factors, development, and prevention of malignancy (Bird 1987) . The dose of the bark extract of B. cuspidata used -200 or 400 mg⁄kg of body weight -may be classified as the normodose or standard dose. The extract of bark of B. cuspidata showed significant hepatoprotective effects, stimulated the antioxidant defense system and reduced the morphological and functional liver damage in Wistar rats exposed to carbon tetrachloride (CCl 4 ) (Gonçalves et al. 2014 ). The antioxidant activity of some aqueous and ethanolic extracts of Chinese medicinal plants have been positively correlated to the content of polyphenols and flavonoids (Cai et al. 2004; Zhang et al. 2011) . Other similar studies have demonstrated the antioxidant activity of polyphenols from Solanum melongena (Kimura et al. 1999) and Croton cajucara (Tieppo et al. 2006) , which presented a high concentration of phenolic compounds that were able to suppress the oxidative stress in liver tissue. In the present study, the preliminary phytochemical analysis indicated the presence of flavonoids and polyphenolic compounds -important antioxidant compounds It has already been established that the toxicity of DMH manifests as systemic effects such as lethargy, anorexia, and progressive weight loss in the animals. In this study, none of these effects were observed in the DMH-treated animals; there was weight gain in all the groups. The LSI was higher in the groups treated with DMSO and B400, suggesting increased hepatic fibrosis in these groups. However, LSI is a low-specificity marker and further analysis, such as, a count of collagen fibers is necessary to confirm the fibrosis. Traditionally, measurement of liver-specific serum enzyme levels has served as a good indicator of liver damage (Sreelatha et al. 2009; Ranawat et al. 2010) . AST enzyme is found in high concentrations in a number of tissues, such as heart, liver, skeletal muscle, kidney, and pancreas.
ALT is primarily limited to the cytosol of hepatocytes and is considered a highly sensitive indicator of hepatocellular damage, and within certain limits, can provide a quantitative ratio of the degree of damage suffered by the liver (AlHabori et al. 2002) . In this study, the AST and ALT levels, important markers of liver dysfunction, were not influenced by the consumption of the bark extract of B. cuspidata. In contrast, higher levels of ALP were found in the animals receiving DMSO, B200, and B400, compared to the saline group. The concentration of ALP could be used as a biomarker of diseases, and monitoring ALP levels would be useful to assess the liver when medication, or drugs damaging to the liver are taken; the same could also be true for monitoring the effectiveness of the treatments. For DMH to exert a carcinogenic effect, it must be metabolized in the liver (Rosenberg et al. 2009) .Its metabolites are then taken to the colon through the blood and bile (Sengottuvelan et al. 2006 ). There, DMH can induce precancerous lesions as the metabolites generate reactive carbon ions that are capable of methylating DNA, RNA, and colonocyte proteins (Rosenberg et al. 2009 ). DMH also induces point mutations, micronuclei, and sister chromatid exchanges, and produces free radicals (Sengottuvelan et al. 2006) . These lead to apoptosis of colonocytes and stimulate cell proliferation, which causes the appearance of precancerous lesions in the colon tissue (Newell and Heddle 2004) .To determine the effects of B. cuspidata on the hepatic antioxidant enzymes in the rats after the induction of the ACF with DMH, the CAT and SOD activities were measured. The DMSO, B200, and B400 groups presented lower SOD activity than the saline group, indicating that the DMSO and extract protected the liver and prevented increased expression of SOD, probably by suffering less tissue destruction by the action of free radicals that were generated by the application of DMH. No differences were found in the levels of CAT. In addition, the extract B. cuspidata (B200 and B400) did not influence the levels of protein carbonyl. These variations in the activity could be the result of adaptations that occurred on account of the conditions of oxidative stress present in the liver. These results were different from other studies in which B. cuspidata extract effectively inhibited all the markers of oxidative stress induced by CCl 4 in vivo (Gonçalves et al. 2014 ).
The DMSO group showed higher levels of lipid oxidation products, verified by the quantification of MDA. Despite being a substance widely used in the biological assays, DMSO has generated controversy, leading to conflicting opinions. There is no consensus on the volume, dilution, and total amount of DMSO that should be used in the experimental animals (Melo et al. 2008) . DMSO induces side effects. When administered in small doses, it may cause toxic effects to the liver and in larger doses, can cause hepatic steatosis (Mathew et al. 1980) . However, the use of this substance in this study is justified by the good solubility of bark extract and the ability of DMSO to easily penetrate the organs, tissues, and membranes, including cellular and intracellular penetration after an intraperitoneal injection (Szmant 1975) . Treatment with the extract of the bark at 400 mg/kg for 15 weeks reduced the total number of preneoplastic lesions in the intestinal mucosa of rodents, indicating that the extract in high concentrations protected the colonic mucosa from developing ACF. This result could be explained by high levels of phenolic compounds found in the extract. Treatment with a lower dose of extract (200 mg/kg) did not exert a chemo-preventive effect. The high concentration of antioxidant compounds present in the B400 group could explain the reduction in preneoplastic lesions. Shwter et al (2014) evaluated the anticarcinogenic activity of the ethanolic extract of Gynura procumbens on colorectal cancer induced by azoxymethane in Sprague-Dawley rats. The doses of extract (250 and 500 mg/kg body weight) used decreased the incidence of ACF in the colons of the animals after 10 weeks of treatment. Phenolic compounds were the predominant antioxidant constituents in G. procumbens. A similar result was found by Almagrami et al (2014) in the rats with induced colorectal cancer and treated with the ethanolic extract of Acanthus ilicifolius (250 and 500 mg/kg body weight) for eight weeks. Polyphenols and flavonoids may inhibit the carcinogenesis by affecting the molecular events in the initiation, promotion, and progression stages. The mechanisms used by these compounds to inhibit the carcinogenic process include antioxidant action, modulation of several protein functions, modulation of the secretion of protein kinases in tumor cell proliferation, induction of the expression of anticarcinogenic enzymes, inhibition of induction of cancer-promoting enzymes, activation of detoxifying enzymes, and increased cell-to-cell communication, among others (Cai et al. 2004; Shwter et al. 2014 ). This study demonstrated that the extract of the bark of B. cuspidata at 400 mg/kg for 15 weeks reduced preneoplastic colorectal lesions in an animal model of colon cancer. The results indicated a possible dose-dependent effect of B. cuspidata extract. Further pharmacological evaluations are essential to elucidate the detailed mechanism of action of this extract, which may have a high potential for the prevention and treatment of preneoplastic colorectal lesions.
